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Genetic mutation in male patients with
incontinentia pigmentiDear Sir,
Hsiao et al identified the NEMO gene mutations in 14 of 21
(66.7%) Chinese patients with incontinentia pigmenti,1
which is similar to the detection rates in the literature.2
However, Hsiao et al reported that no NEMO mutation was
detected in the male patient with typical linear vesicles as
a newborn, streaks of hypopigmentation at 2 months of
age, typical vesicle histology and normal 46, XY karyotype.
We also had a 14-day-old, full-term baby (38 weeks of
gestation) admitted to the National Taiwan University
hospital due to multiple erosive skin rashes over the right
anterior tibia area at birth and several vesicles developed
over the same site in the following days. The karyotype of
the newborn was 46, XY. The mother also had multiple
hyperpigmentation patches over bilateral lower legs but
she denied previous vesicles, ophthalmologic problems,
dental problems or neurologic deficit. However, no NEMO
mutation was detected by multiplex PCR and sequencing.
Ardelean et al reviewed the literature and only 5 out 42
(12%) male patients with incontinentia pigmenti had
evidence of NEMO gene mutation.3 The three mechanisms
for survival of males with incontinentia pigmenti were
hypomorphic alleles, the 47, XXY karyotype (Klinefelter
syndrome) and somatic mosaicism.4 Although somatic
mosaicism is possible in these two affected males, there
may be some other etiology or causative gene mutation of
the incontinentia pigmenti.
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